Rhumbline Advisers Purchases 35,026 Shares of CVS Health Co. (NYSE:CVS)

Rhumbline Advisers increased its position in CVS Health Co. (NYSE:CVSFree Report) by 1.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,652,428 shares of the pharmacy operator’s stock after purchasing an additional 35,026 shares during the period. Rhumbline Advisers owned approximately 0.21% of CVS Health worth $119,067,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. ABC Arbitrage SA bought a new position in shares of CVS Health in the 4th quarter worth $1,191,000. Valeo Financial Advisors LLC raised its position in CVS Health by 1.8% in the 4th quarter. Valeo Financial Advisors LLC now owns 28,957 shares of the pharmacy operator’s stock valued at $1,300,000 after buying an additional 500 shares during the last quarter. V Square Quantitative Management LLC raised its position in CVS Health by 16.4% in the 4th quarter. V Square Quantitative Management LLC now owns 18,347 shares of the pharmacy operator’s stock valued at $824,000 after buying an additional 2,586 shares during the last quarter. Root Financial Partners LLC purchased a new stake in CVS Health in the 4th quarter valued at $248,000. Finally, MidAtlantic Capital Management Inc. raised its position in CVS Health by 112.1% in the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator’s stock valued at $37,000 after buying an additional 437 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Down 1.0 %

Shares of NYSE CVS opened at $65.71 on Friday. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The business has a 50-day simple moving average of $51.11 and a two-hundred day simple moving average of $56.08. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a market cap of $82.68 billion, a P/E ratio of 16.68, a P/E/G ratio of 0.60 and a beta of 0.61.

CVS Health (NYSE:CVSGet Free Report) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. Research analysts anticipate that CVS Health Co. will post 5.14 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.05%. CVS Health’s dividend payout ratio is currently 67.51%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on CVS shares. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target for the company in a research report on Tuesday, December 3rd. Mizuho lowered their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Cantor Fitzgerald raised CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 30th. Finally, Barclays raised their target price on CVS Health from $71.00 to $73.00 and gave the company an “overweight” rating in a research report on Thursday. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $70.28.

View Our Latest Analysis on CVS Health

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Articles

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.